---
id: infectious-esophagitis_291
category: clinical-syndromes
tags: [esophagitis, candida, CMV, HSV, immunocompromised, HIV]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Infectious Esophagitis: Diagnosis and Treatment

**Q:** What are the major causes of infectious esophagitis in immunocompromised patients, and how is each treated?

**A:**

**Major Causes (HIV patients with CD4 <200):**

| Pathogen | Clinical Features | Endoscopic Findings | Treatment |
|----------|-------------------|---------------------|-----------|
| ***Candida*** (most common) | Odynophagia + **oral thrush (66%)** | White plaques | **Fluconazole 200-400 mg PO/IV daily × 14-21 days** |
| **CMV** | Odynophagia + **systemic symptoms** (fever, N/V, abdominal pain) in 20-40% | Large, deep ulcers (usually distal esophagus) | **Ganciclovir 5 mg/kg IV q12h** OR valganciclovir 900 mg PO BID × 3-6 weeks (induction) |
| **HSV** (type 1 >> type 2) | Odynophagia (acute onset) | Small, discrete ulcers (proximal/mid esophagus) | **Acyclovir 400 mg PO 5×/day** OR valacyclovir 1 g PO TID × 14-21 days (immunocompromised) |

**Co-Infection:**
- 20% have simultaneous *Candida* + CMV
- 2% have *Candida* + CMV + HSV
- 2% have HSV + CMV

**Diagnostic Approach:**

**Empiric Trial:**
- Oral thrush + odynophagia → **Empiric fluconazole × 5-7 days**
- **If no improvement in 5-7 days** → **EGD with biopsy**

**Endoscopy Indications:**
- Failed empiric therapy
- Severe symptoms
- No oral thrush (consider CMV/HSV)
- Need to rule out other causes (pill esophagitis, reflux, malignancy)

**Biopsy Findings:**
- *Candida*: Yeast/pseudohyphae on surface
- CMV: **"Owl's eye" inclusions** in endothelial/stromal cells
- HSV: **Multinucleated giant cells** at ulcer margin (Cowdry type A inclusions)

**Pearl:** Oral thrush + odynophagia has high PPV for candida esophagitis; CMV usually occurs with CD4 <50 and often disseminated.

**Media:**

**Sources:** [PMC6939767 - Infectious Esophagitis Immunosuppressed], [Merck Manual Infectious Esophageal Disorders], [NIH HIV OI Guidelines Candidiasis], [PMC4027832 - Etiology Diagnosis Treatment]
